Top Markets
#1 Ontology Gas Ontology Gas +23.38%
#2 EXOD EXOD +22.08%
#3 Status Status +20.38%
#4 ETHGas ETHGas +14.18%
#5 aelf aelf +13.27%
#6 Fake World Assets Fake World Assets +10.63%
#7 The Black Bull The Black Bull +10.03%
#8 Derive Derive +8.64%
#9 Gas Gas +7.44%
#10 Meteora Meteora +6.38%
Coin of the day
Ontology Gas Ontology Gas
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
LAVA Therapeutics N.V. LAVA Therapeutics N.V.

LAVA Therapeutics N.V.

LVTX
Classifica tra le azioni #25837
LAVA Therapeutics N.V. is an immuno-oncology firm, currently in the clinical... LAVA Therapeutics N.V. is an immuno-oncology firm, currently in the clinical development phase, dedicated to pioneering novel therapies for cancer. Utilizing its proprietary Gammabody platform, the company engineers innovative bispecific antibodies. These antibodies are specifically designed to engage and harness the potent and precise capabilities of gamma delta T cells, aiming to stimulate a robust anti-tumor immune response and ultimately enhance outcomes for individuals battling cancer. Key compounds in its clinical pipeline include LAVA-051, currently undergoing Phase 1/2a trials for various hematologic malignancies such as chronic lymphocytic leukemia, multiple myeloma, and acute myeloid leukemia. Another front-runner, LAVA-1207, is also in Phase 1/2a clinical studies, targeting metastatic castration-resistant prostate cancer. Furthermore, LAVA Therapeutics is advancing additional Gammabody candidates: LAVA-1223, an investigational treatment for specific solid tumors that targets the epidermal growth factor receptor (EGFR), and preclinical assets LAVA-1266 and LAVA-1278, intended for a range of blood cancers. The company has also forged a research collaboration and licensing partnership with Janssen Biotech, Inc. This alliance focuses on the potential discovery and development of multi-specific antibody therapies aimed at a particular target across diverse therapeutic applications. Established in 2016, LAVA Therapeutics N.V. operates from its headquarters in Utrecht, the Netherlands.
Prezzo delle azioni
$1.74
Ultima sincronizzazione: 2025-11-28
Capitalizzazione di mercato
$45.77M
Variazione (1 giorno)
0.00%
Variazione (1 anno)
12.26%
Paese
NL
Scambia LAVA Therapeutics N.V. (LVTX)

Categoria

Healthcare
Storico del prezzo dell'azione per LAVA Therapeutics N.V. (LVTX)
Prezzo di chiusura più alto: $1.68 il 2025-11-01

Prezzo di chiusura più basso: $13.74 il 2021-03-01
Storico del prezzo dell'azione di LAVA Therapeutics N.V. dal 2021 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) -5.21%
2025 33.22%
2024 -17.20%
2023 -67.44%
2022 -17.89%
2021 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $539.14 35.65%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.04K 56.21%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $119.20 -17.89%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $761.87 8.65%
CH
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $130.43 397.46%
US